Apotex Health Corp. Reports Second Quarter 2027 Financial Results and Raises Fiscal Year 2027 Guidance

Apotex Health Corp. reported strong second-quarter fiscal 2027 performance and raised its full-year fiscal 2027 guidance. The company, Canada’s largest pharmaceutical company, manages a portfolio of generic, biosimilar and branded medicines. The report did not provide specific financial figures or stock-price movements.